Deterministic and stochastic epidemics with several kinds of susceptibles

From MaRDI portal
Publication:3688151

DOI10.2307/1427049zbMath0571.92019OpenAlexW4249260851MaRDI QIDQ3688151

Frank G. Ball

Publication date: 1985

Published in: Advances in Applied Probability (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/1427049



Related Items

The final size of an epidemic and its relation to the basic reproduction number, Heterogeneity in susceptibility to infection can explain high reinfection rates, Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold, A theoretical framework to identify invariant thresholds in infectious disease epidemiology, How population heterogeneity in susceptibility and infectivity influences epidemic dynamics, Herd immunity under individual variation and reinfection, The effect of population heterogeneities upon spread of infection, SIR epidemics and vaccination on random graphs with clustering, On the correlation between variance in individual susceptibilities and infection prevalence in populations, Multigeneration reproduction ratios and the effects of clustered unvaccinated individuals on epidemic outbreak, Bounding the Size and Probability of Epidemics on Networks, The size of epidemics in populations with heterogeneous susceptibility, Epidemic dynamics with a time-varying susceptibility due to repeated infections, Reproduction numbers and thresholds in stochastic epidemic models. I: Homogeneous populations, The effect of preferential mixing on the growth of an epidemic, Mixture representation for order statistics from INID progressive censoring and its applications, Coupling of Two SIR Epidemic Models with Variable Susceptibilities and Infectivities, Final attack ratio in SIR epidemic models for multigroup populations, What the reproductive number \(\mathcal{R}_0\) can and cannot tell us about COVID-19 dynamics, Stochastic Epidemic Modeling, Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity